Skip to content

Clinical trials

Carcinoma, Bronchogenic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Country / region: France Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20151
20161
20174
20192
20203
20213
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Active, not recruiting3
Recruiting3
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Blueprint Medicines Corporation2
Hoffmann-La Roche2
AstraZeneca1
Centre Hospitalier Universitaire Dijon1
Centre Hospitalier de PAU1
Fondation Hôpital Saint-Joseph1
Hospices Civils de Lyon1
Institut du Cancer de Montpellier - Val d'Aurelle1
RENAULT Patrick Aldo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic19
Lung Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Lung Diseases9
Neoplasms9
Neoplasms by Site9
Respiratory Tract Diseases9
Respiratory Tract Neoplasms9
Thoracic Neoplasms9
Bronchial Neoplasms7

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.